Vincenzo Tombolini

Full Professor

Università degli Studi di Roma La Sapienza Dipartimento di Scienze Statistiche

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Vincenzo Tombolini is a Full Professor at Università degli Studi di Roma La Sapienza, Italy. His research primarily focuses on the application of genomics and immune therapies in oncology, particularly in head and neck cancers, as well as the use of machine learning techniques for predicting treatment responses in various cancer types. Recent publications highlight his work on the combination of immunotherapy approaches and the analysis of salivary biomarkers in cancer treatments.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (16)

Daniela MESSINEO

Associate Professor

Sapienza University of Rome

ITALY

Vincenzo Tombolini

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Genomic and Immune Approach in Platinum Refractory HPV-Negative Head and Neck Squamous Cell Carcinoma Patients Treated with Immunotherapy: A Novel Combined Profile

Relationship between Salivary Amylase and Xerostomia in Intensity-Modulated Radiation Therapy for Head and Neck Cancer: A Prospective Pilot Study

Performance of Machine Learning and Texture Analysis for Predicting Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer with 3T MRI

Dental Implant Failure Risk in Post Oncological Patients, a Retrospective Study and Sapienza Head and Neck Unit Decisional Protocol- 7 Years of Follow-Up

A Machine-Learning-Based Bibliometric Analysis of the Scientific Literature on Anal Cancer

COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2

MS−275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells

Immune Check-Point Inhibitors and Standard Chemoradiotherapy in Definitive Head and Neck Cancer Treatment

Targeted Molecular Therapy in Glioblastoma

Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines in Vitro and in Vivo

Collaborators (16)

Daniela MESSINEO

Michela BUGLIONE DI MONALE E BASTIA

Umberto Romeo

marco rengo

Pierfrancesco Franco

Alessandro Corsi

Cira di Gioia

Davide Bellini

RAFFAELLA DE PIETRO

Paolo Marchetti

Marco Krengli

Akira Hara

claudio festuccia

Silvia MEZI

CINZIA MARCHESE

David Sebag-Montefiore

Make your next move.